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Abstract: Melanoma chondroitin sulphate proteoglycan (MCSP) is a cell-surface antigen that has been implicated in the growth and invasion of melanoma tumors. Although this antigen is expressed early in melanoma progression, its biological function is unknown. MCSP
can stimulate the integrin-α4β1-mediated adhesion and spreading of melanoma cells. Here we show that stimulated MCSP recruits tyrosine-phosphorylated p130cas, an adaptor protein important in tumor cell motility and invasion. MCSP stimulation also results in a pronounced activation and recruitment of the Rho-family GTPase Cdc42. MCSP-induced spreading of melanoma cells is dependent upon
active Cdc42, a Cdc42-associated tyrosine kinase (Ack-1) and tyrosine phosphorylation of p130cas. Furthermore, vectors inhibiting Ack-1
or Cdc42 expression and/or function abrogate MCSP-induced tyrosine phosphorylation and recruitment of p130cas. Our findings indicate
that MCSP may modify tumor growth or invasion by a unique signal-transduction pathway that links Cdc42 activation to downstream tyrosine phosphorylation and subsequent cytoskeletal reorganization.
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etastasis of tumor cells requires rapid, dynamic regulation of
cell-surface adhesion receptors important for migration, invasion, extravasation and growth. One group of proteins involved in
tumor adhesion is the integrins, a family of heterodimeric adhesion
receptors fundamentally important to mediating cell–cell and cell–
extracellular matrix (ECM) interactions1. In particular, integrin α4β1
has been implicated in tumor cell invasion and metastasis2,3. Although integrin α4β1 is expressed in a variety of malignancies, such
as melanoma4,5, and α4β1 expression has been linked to melanoma
progression6, the mechanism by which tumor cells modulate integrin
adhesiveness is not fully understood. However, clustering of integrins triggers a cascade of intracellular signalling pathways leading to
the phosphorylation of cytoplasmic and cytoskeletal substrates, such
as focal adhesion kinase (FAK), paxillin and p130cas (refs 1, 7–9).
Furthermore, both p130cas and FAK play a part in integrinmediated
tumor cell migration10,11, indicating that modifying integrin signalling pathways may stimulate tumor invasion and metastasis.
Cell-surface proteoglycans are a second group of adhesion receptors that mediate both cell–cell and cell–ECM interactions12. Many
ECM proteins contain closely spaced proteoglycan- and integrinbinding domains, indicating that these two distinct types of adhesion
receptor may generally function in concert to stimulate cytoskeletal
reorganization, migration and invasion. Of the proteoglycans, MCSP
is abundantly and ubiquitously expressed on most human melanoma cells, whereas its expression is lower on normal melanocytes13.
MCSP may be involved in the spreading, migration and invasion of
melanoma cells, as antibodies directed against MCSP inhibit these
processes in vitro14,15. We have shown previously that MCSP enhances α4β1 integrin function16–19, in part by stimulating signalling
pathways involving tyrosine kinases17.

Members of the Rho family of GTPases, Rho, Rac and Cdc42,
regulate cytoskeletal rearrangements, leading to the formation of actin stress fibres, lamellipodia and filopodia, respectively20,21. The cooperative signalling of integrin and syndecan proteoglycan that leads
to the assembly of focal adhesions has been shown to be Rho dependent22. Integrin-β1-mediated signalling has also been linked to cytoskeletal rearrangements through functional interactions of Cdc42
with phosphatidylinositol-3-OH kinase (PI(3)K) and potentially
FAK23,24, indicating that Rho-family GTPases may be responsible
for regulating adhesive signals mediated by both integrins and cellsurface proteoglycans.
Members of the Ack (activated-Cdc42-associated kinase)
family of non-receptor tyrosine kinases act as potentially important links between certain activated Rho-family GTPases (such as
Cdc42) and signalling pathways. Members of this family interact
specifically with the GTP-bound (active) form of Cdc42 (refs 25,
26). Ack-1 is homologous to FAK in its kinase and proline-rich domains, as well as to Src in its kinase and Src homology 3 (SH3) domains25, indicating that Ack-1 may interact with, and phosphorylate, effector proteins similar to those that interact with FAK and
Src. Ack-2 is a structural variant of Ack-1; it lacks 344 residues
within the proline-rich carboxy-terminal tail25. Activated Ack-2 coprecipitates with β1 integrin27, suggesting a role for this family of
kinases in modulating cell adhesion.
We show here that clustering of MCSP activates Cdc42 to a
GTP-bound state. Furthermore, activated MCSP recruits a signalling complex that includes activated Cdc42 and Ack-1. Formation
of this complex results in recruitment and tyrosine phosphorylation
of p130cas and subsequently enhances α4β1-integrin-mediated melanoma cell spreading.
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Figure 2 MCSP-induced α4β1-integrin-dependent cell spreading involves p130cas
signalling. Untransfected (a–c) or A375SM cells transfected with vector alone (d–
f) or p130cas SH3 vector (g–i) were allowed to adhere and spread for 1 h on plates
coated with rIIIcs (a, d, g), monoclonal antibody 9.2.27 (b, e, h) or both (c, f, i). The
arrowheads denote CaptureTec transfectant selection beads bound to cells. Original
magnification ×40; scale bar represents 5 μm.

in a time-dependent manner following MCSP clustering (Figure 1a).
Furthermore, MCSP-induced phosphorylation of p130 was sensitive
to genistein (Figure 1b), indicating that p130 tyrosine phosphorylation may influence MCSP-induced signal transduction leading to integrin-mediated cell spreading.
Figure 1 MCSP clustering induces tyrosine phoshorylation of p130cas . NM, immunoprecipitation with mouse IgG. a, Clustering of MCSP induces tyrosine phosphorylation of a protein of Mr 130K (p130) in a time-dependent manner. b, MCSP-induced
tyrosine phosphorylation of p130 is sensitive to the tyrosine kinase inhibitor genistein.
c, d, MCSP clustering is required for tyrosine phosphorylation (c) and recruitment (d)
of p130cas. In c, d, lanes 1–3 depict unclustered samples in which cells were initially
lysed and immunoprecipitated with mouse IgG (NM) or monoclonal antibodies against
class I MHC or MCSP. Immunoprecipitates were released and re-immunoprecipitated
with anti-p130cas monoclonal antibody (c, d) and then blotted with antibody against
phosphorylated tyrosine (c) or p130cas (d). Lanes 4, 5 show cells that were incubated
with either anti-MHC or anti-MCSP-coated beads to cluster the antigen. Cells were
then lysed, and MHC- or MCSP-associated proteins were re-immunoprecipitated with
anti-p130cas monoclonal antibody and then blotted with antibody against phosphorylated tyrosine (c) or p130cas (d). PY, phosphorylated tyrosine.

Results
MCSP clustering induces tyrosine phosphorylation of a p130
protein. We have shown previously that cooperative stimulation of
both MCSP and α4β1 integrin induces cell spreading and focal-contact formation in A375SM human melanoma cells17. The cytoskeletal rearrangements delineating this morphology were, in part, dependent upon tyrosine kinases, as shown by an inhibition of melanoma
cell spreading and focal-contact formation upon pretreatment with
a tyrosine kinase inhibitor, genistein17. Hence, we have now evaluated a role for tyrosine phosphorylation in MCSP-induced signalling
pathways. Signal transduction was stimulated in A375SM human
melanoma cells by addition of magnetic beads coated with 9.2.27, a
monoclonal antibody directed towards the MCSP core protein. MCSP
and its associated proteins were separated by SDS–polyacrylamide
gel electrophoresis (SDS–PAGE) and immunoblotted. Blots probed
with anti-phosphotyrosine monoclonal antibodies showed a protein
migrating at relative molecular mass 130,000 (Mr 130K; p130) (Figure 1a). Tyrosine phosphorylation of p130 was specific and occurred

MCSP clustering induces p130cas recruitment and phosphorylation. We then re-immunoprecipitated MCSP-associated proteins with antibodies directed against various proteins of Mr 130K.
A monoclonal antibody recognizing p130cas immunoprecipitated a
MCSP-associated protein of Mr 130K (Figure 1c, lane 5). Although
p130cas did not associate with MCSP in the absence of clustering,
clustering of MCSP induced both the recruitment and the tyrosine
phosphorylation of p130cas (Figure 1c, d, lanes 3, 5). Clustering of
another cell-surface receptor, the class I major histocompatability
complex (MHC), by an isotype-matched monoclonal antibody did
not induce p130cas recruitment or tyrosine phosphorylation (Figure
1c, d, lanes 2, 4). These results indicate that, under these experimental conditions, recruitment and tyrosine phosphorylation of p130cas
specifically require MCSP stimulation.
p130cas is required for MCSP-induced α4β1-mediated cell spreading. We next evaluated the requirement for p130cas in MCSP-induced
melanoma-cell spreading by using a dominant-negative p130cas
SH3 construct that binds to a proline-rich span in proteins such as
FAK10. As reported previously, both untransfected and mock-transfected A375SM melanoma cells adhered but did not spread when either α4β1 integrin or MCSP was engaged alone on rIIICS- or 9.2.27coated plates, respectively (Figure 2a, b, d, e)17. Only when MCSP
and α4β1 integrin were engaged cooperatively was cell spreading observed (Figure 2c, f). Cells transfected with the dominant-negative
p130cas SH3 construct were unable to spread on a substrate engaging
both MCSP and α4β1 integrin (Figure 2g–i). To determine whether
tyrosine phosphorylation of p130cas was required for MCSP-induced
cell spreading, we transfected cells with p130cas(ΔSD), a mutated
p130cas that lacks residues 119–420, which include multiple YXXP
motifs (single-letter amino-acid code) that function as tyrosine kinase substrates11,28. Cells transfected with p130cas(ΔSD) failed to
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Figure 3 Activated Cdc42 associates with MCSP and induces spreading of melanoma cells. a, Clustering of MCSP specifically recruits Cdc42. b, Cdc42 is specifically activated upon stimulation of MCSP, as determined by interaction with PAK binding domain (PBD)-coated beads, which bind preferentially to active Cdc42 or Rac. c, d, Untransfected
(UT) or vector-transfected (mock) A375SM cells (c, d), or A375SM cells transfected with dominant-negative Cdc42 (Cdc42(17N)) (c) or constitutively active Cdc42 (Cdc42(12V))
(d) were allowed to adhere and spread on plates coated with rIIIcs, monoclonal antibody 9.2.27 or both rIIIcs and 9.2.27. *P < 0.001 compared with untransfected cells.

spread on a substrate engaging both MCSP and α4β1 integrin (data
not shown). Collectively, these data indicate that recruitment and tyrosine phosphorylation of p130cas function in mediating MCSP-induced signal-transduction pathways leading to α4β1-integrin-dependent spreading of melanoma cells.
Cdc42 associates with MCSP upon MCSP clustering. Previous
studies have localized MCSP to microspikes and filopodia of cultured melanoma cells, indicating that MCSP may mediate early
cell–matrix recognition events important to the process of cell adhesion29. As the Rho-family GTPase Cdc42 stimulates filopodia
formation in fibroblasts21, we next determined whether Cdc42 associates with MCSP. We incubated A375SM melanoma cells with
magnetic beads coated with monoclonal antibody 9.2.27 or P4C2
(anti-α4-integrin antibody), and analysed associated proteins for the
presence of Cdc42 by immunoblotting. In the absence of adhesionreceptor clustering, Cdc42 showed a low level of constitutive association with MCSP but not with α4β1 integrin (Figure 3a, lanes 3,
4). This association was markedly enhanced (about 4.4-fold, as determined by densitometry) upon MCSP clustering (Figure 3a, lane
7; data not shown). MCSP-associated Cdc42 represents ~59% of
total cellular Cdc42 (data not shown). Clustering of α4β1 integrin,
however, did not induce Cdc42 association with the integrin (Figure 3a, lane 6). We also determined the activation state of Cdc42
upon MCSP stimulation. Using the PAK binding domain (PBD) of
PAK3, which binds preferentially to GTP-bound Cdc42 or Rac, we
found that MCSP stimulation resulted in a rapid and robust activation of Cdc42 (Figure 3b). Furthermore, MHC stimulation did not
induce Cdc42 activation (Figure 3b), indicating that MCSP activation of Cdc42 is specific.
To determine whether Cdc42 influences MCSP-induced signal
transduction leading to α4β1-integrin-dependent cell spreading, we
transfected cells with expression vector alone or with constructs encoding Cdc42 as a dominant-negative (Cdc42(17N)) or constitutively
active (Cdc42(12V)) enzyme. We assayed transfected cells for cell
spreading as described above. Unlike both untransfected and mock-

transfected cells, cells transfected with Cdc42(17N) adhered but did
not spread when both MCSP and α4β1 integrin were engaged (Figure
3c). Furthermore, melanoma cells transfected with Cdc42(12V) fully
spread when α4β1 integrin alone was engaged on rIIIcs-coated plates,
bypassing the requirement for MCSP engagement in inducing α4β1integrin-mediated cell spreading (Figure 3d). Together, these data implicate Cdc42 in mediating post-adhesion cytoskeletal changes following engagement of MCSP and α4β1 integrin in A375SM human
melanoma cells.
Cdc42(17N) inhibits MCSP-induced p130cas recruitment and
phosphorylation. To assess the role of Cdc42 in signal transduction
from MCSP, we studied the effects of mutant Cdc42 constructs on
MCSP-induced recruitment and tyrosine phosphorylation of p130cas.
Cells were transfected with either vector alone or Cdc42(17N).
Transfected cells were incubated with 9.2.27-coated magnetic beads
to induce tyrosine phosphorylation of p130cas . Melanoma cells expressing dominant-negative Cdc42 failed to recruit or tyrosine phosphorylate p130cas upon MCSP stimulation (as compared with both
mock-transfected and untransfected cells) (Figure 4a, b). Cells transfected with a constitutively active Cdc42 construct showed enhanced
p130cas recruitment and subsequent tyrosine phosphorylation upon
clustering of MCSP (data not shown). Hence, the GTPase Cdc42

Figure 4 Cdc42 mediates MCSP-induced p130cas recruitment and tyrosine phosphorylation. A375SM cells that were untransfected (UT) or transfected with vector
alone (mock) or dominant-negative Cdc42 (Cdc42(17N)) were incubated with beads
coated with monoclonal antibody 9.2.27, which induced clustering of MCSP and tyrosine phosphorylation (a) and recruitment (b) of p130cas .
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Figure 5 Ack-1 kinase activity is associated with MCSP. a, In vitro kinase activity of
a 120K–130K protein is specifically associated with MCSP. b, Immunodepleting Ack1 kinase from cell lysates subsequently ablates the 120K–130K MCSP-associated in
vitro kinase activity.

is involved in activating MCSP induced tyrosine-kinase pathways
that lead to the recruitment and tyrosine phosphorylation of p130cas .
Ack-1 associates with MCSP. As association of Cdc42 with MCSP
induced tyrosine phosphorylation of p130cas, we proposed that activated Cdc42-associated kinase-1 (Ack-1) might mediate this phosphorylation. We lysed A375SM melanoma cells and immunoprecipitated proteins by using antibodies directed against MCSP, class I
MHC or α4β1 integrin under mild detergent conditions. Subsequent
in vitro kinase assays (performed in the absence of exogenous sub-
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strates) showed that neither class I MHC nor α4β1 integrin exhibited
significant associated kinase activity under these experimental conditions (Figure 5a, lanes 3, 4), but anti-MCSP immunoprecipitates
yielded a band at an M value of ~120–130K (Figure 5a, lane 2). To
identify this protein(s), we sequentially immunodepleted MCSP-associated proteins by using antibodies that recognize various proteins
of ~120–130K, such as FAK, p130cas, vinculin and Ack-1. Immunodepleted lysates were then assayed for any remaining MCSP-associated kinase activity.
Using this immunodepletion technique, we found that the MCSPassociated kinase activity was attributable to Ack-1, as only the depletion of Ack-1 completely inhibited the association of the 120–
130K protein(s) with MCSP (Figure 5b, lane 1; data not shown).
These data indicate that the 120–130K band may represent either
Ack-1 or a substrate of Ack-1, but not phosphorylated p130cas, as lysates depleted of p130cas still showed significant MCSP-associated
kinase activity (data not shown).
To determine whether Ack-1 participates in MCSP-induced signal transduction leading to integrin-mediated cytoskeletal changes,
we constructed an Ack-1 antisense expression vector and expressed
it in A375SM melanoma cells to inhibit Ack-1 protein expression.
To confirm that the antisense vector was expressed, we assayed
Ack1 kinase activity using myelin basic protein (MBP) as an exogenous substrate (Figure 6a). This assay confirmed that antisense
Ack-1 expression inhibits Ack-1 kinase activity. The Ack-1 kinase
activity in mock-transfected and untransfected cells was unaffected
(Figure 6b). Melanoma cells expressing the Ack-1 antisense construct adhered, but did not spread, on a substrate engaging both
α4β1 integrin and MCSP (Figure 6b). These data are consistent with
a role for Ack-1 in MCSP-induced signalling pathways that stimulate cytoskeletal rearrangements.
Ack-1 mediates MCSP-induced p130cas tyrosine phosphorylation.
We next determined whether p130cas was a target substrate for Ack-1
in MCSP-induced signal-transduction pathways. Cells that were untransfected, mock transfected or transfected with the Ack-1 antisense
construct were incubated with magnetic beads coated with monoclonal antibody 9.2.27 to induce p130cas recruitment and tyrosine phos-

Figure 6 Ack-1 kinase induces spreading of melanoma cells and tyrosine phosphorylation of p130cas. a, Expression of Ack-1 antisense vector inhibits Ack1 in vitro kinase
activity, as determined by phosphorylation of an exogenous substrate, myelin basic protein (MBP). b, Untransfected A375SM cells (UT) or A375SM cells transfected with either
vector alone (mock) or Ack-1 antisense vector were allowed to adhere and spread on plates coated with rIIIcs, monoclonal antibody 9.2.27, or both. *P < 0.001 compared with untransfected cells. c, Untransfected A375SM cells (UT) or A375SM cells transfected with vector alone (mock) or Ack-1 antisense vector were clustered with 9.2.27-coated beads to
induce tyrosine phosphorylation of p130cas. d, Untransfected A375SM cells (UT) or cells transfected with mock or Ack-1 kinase-dead (kd) vector were clustered with 9.2.27-coated
beads to induce tyrosine phosphorylation and recruitment of p130cas.
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phorylation. Melanoma cells expressing Ack-1 antisense constructs
failed to recruit and tyrosine phosphorylate p130cas upon MCSP clustering (Figure 6c), indicating that p130cas may be a downstream target of Ack-1. To determine whether the kinase activity of Ack-1 is
specifically required for signalling from MCSP, we transfected melanoma cells with a kinase-dead Ack-1 construct, Ack1(K163A) (Figure 6d). Cells transfected with this kinase-dead construct failed to either recruit or tyrosine phosphorylate p130cas upon MCSP clustering.
Together, these data illustrate the importance of Ack-1 kinase activity
in propagating MCSP-induced signal transduction, ultimately leading to α4β1-integrin-mediated spreading of melanoma cells.
Discussion
Our previous studies showed that MCSP stimulates α4β1-integrinmediated adhesion and spreading of melanoma cells16–19, in part through
the involvement of activated tyrosine kinases17. Here, we have shown
that signalling through MCSP induces the recruitment and tyrosine
phosphorylation of p130cas. We propose a unique MCSP-induced
signalling pathway that integrates both activated Cdc42 and Ack-1,
thereby stimulating the downstream recruitment and tyrosine phosphorylation of p130cas .
Using dominant-negative p130cas constructs, we showed that
p130cas promotes MCSP-induced α4β1-integrin-mediated cytoskeletal rearrangements. Phosphorylation of p130cas has been implicated
in integrin-induced signal-transduction pathways; upon integrin engagement, p130cas is tyrosine phosphorylated through interactions of
FAK/Src with the SH3 domain of p130cas (refs 28, 30, 31). p130cas
has also been localized to focal adhesions32. Furthermore, p130cas is
involved both in FAK-mediated migration of CHO cells10 and in promoting integrin-dependent tumor-cell migration and invasion through
coupling with Crk11. These results indicate that phosphorylation of
p130cas by multiple tyrosine kinases may be important for tumor invasion and metastasis by regulating cell adhesion and motility.
Using a metastatic melanoma cell line, we found that MCSP-induced tyrosine phosphorylation of p130cas is dependent on the recruitment and activation of the Rho-family GTPase Cdc42. Although
Cdc42 is important for stimulating filopodia formation and maintaining cell polarity during cell migration21,33, emerging evidence also
implicates activation of Cdc42 in cellular transformation and tumor
progression. For instance, Cdc42 activation confers anchorage-independent growth of rat fibroblasts and is required for Ras-mediated
transformation34. Furthermore, activation of Cdc42 promotes integrin-mediated motility and invasion of breast cancer cells23. On the
basis of our results, we propose that MCSP enhances tumor cell invasion and metastasis by recruiting a signal-transduction complex that
includes active Cdc42.
Our data also show that MCSP-induced sequestration of Cdc42
and tyrosine-phosphorylated p130cas depends upon the activation of
the kinase Ack-1. Ack-1 and Ack-2 associate with the GTP-bound
form of Cdc42 (refs 25–27), and GTP-bound Cdc42 activates autophosphorylation of Ack-2 within cells26. It has, therefore, been proposed that GTP-bound Cdc42 mediates the activation of Ack kinases
by directing their proper cellular localization26. The subcellular localization of Ack kinases by interactions with GTP-bound Cdc42
may enhance the ability of these kinases to recruit and/or phosphorylate target proteins, further propagating signal transduction.
Although MCSP can induce signals independently of integrin engagement, our data also indicate that the signals stimulated by MCSP
are closely related and/or intersect integrin-mediated signal-transduction pathways. For example, tyrosine phosphorylation of p130cas is
also associated with ligation of β1 integrin28,30,31,35,36, indicating that
this adaptor protein may be involved in integrin-mediated adhesion
and motility. Furthermore, Ack-2 co-precipitates with β1 integrin, and
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activation of Ack-2 is required for its association with this integrin27;
however, a direct relationship between Ack-2 and downstream integrin targets such as p130cas or FAK has not been established. Nevertheless, it is possible that MCSP-and α4β1integrin-induced signalling pathways may intersect at multiple points. Such intersections
may help to amplify these signalling pathways at cell–ECM attachment sites, which in turn act to accelerate cytoskeletal reorganization, leading to cell spreading, focal-contact formation and firm adhesion. Studies in which MCSP-induced signals are evaluated in the
absence of functional integrin signalling (for example, using dominant-negative FAK) will be important in defining specific intersection points between MCSP and integrin signalling pathways. Present studies are also focusing on evaluating the potential involvement
of other Rho-family GTPases (such as Rac1 and RhoA) in MCSP-induced signalling, as the activity of Rho-family GTPases can be coordinated in certain cell types21.
The structural features of MCSP that stimulate signal transduction are also being studied. Addition of chondroitin sulphate to the
MCSP core protein confers on the proteoglycan the ability to interact
with the C-terminal heparin-binding domain of fibronectin (and perhaps other matrix proteins). α4 integrin subunits also bind to chondroitin sulphate glycosaminoglycan (CSGAG) through a unique site
on the integrin subunit, termed SG-1, and this interaction may enhance the activation of certain integrins19. CSGAG does not seem
to be involved in MCSP-induced signal transduction, as both cell
spreading and signalling are observed following CSGAG removal
with chondroitinase ABC (J.I., unpublished observations). Instead,
the data support a direct role for the MCSP core protein in signal
transduction. Although the MCSP core protein has no apparent catalytic domains, the cytoplasmic tail of MCSP contains three potential threonine phosphorylation sites37. The importance of these sites
has not yet been established; however, inhibitors of serine/threonine
kinases (such as chelerythrine) inhibit MCSP-induced cell spreading
(J.I., unpublished observations). Collectively, these results indicate
that distinct structural features of MCSP may function to enhance adhesion of melanoma cells by both activating integrins and stimulating signalling pathways that lead to cytoskeletal rearrangement.
MCSP expression in melanoma cells is increased quite early in
tumor progression13,38, indicating that it may also function in melanoma biology in ways that are related to cell growth and survival.
For example, antibodies directed against MCSP inhibit anchorageindependent growth of human melanoma cells and suppress melanoma tumor growth in vivo39,40. Expression of NG2, the rat homologue of MCSP, may also increase both the in vivo tumorigenicity
of melanoma cells in experimental metastasis models and the proliferation of B16 melanoma cells in vitro41. Cdc42 and Ack-2 have
been linked to the activation of a subfamily of mitogen-activated
protein kinases, the c-Jun amino-terminal kinases (JNKs), and
thereby may stimulate gene expression27,42,43. The sequestration/
activation of signalling complexes by MCSP may, therefore, stimulate critical signalling pathways important for controlling growth
and programmed cell death.
Methods
Cell culture.
Highly metastatic A375SM human melanoma cells were selected by in vivo experimental metastasis assays of parent A375P cells in nude mice and were provided by I.J. Fidler44. Cells were maintained in Eagle’s minimal essential media
(EMEM) supplemented with 10% fetal calf serum, 50μgml–1 gentamycin, minimal essential media vitamin solution and 1mM sodium pyruvate. These cells
were routinely used before 15 cell passages.
Antibodies.
Monoclonal antibody 9.2.27, directed towards the MCSP core protein, was a gift
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from R. Reisfeld. The anti-α4-integrin monoclonal antibody P4C2 was provided
by E. Wayner. Anti-p130cas monoclonal antibody was purchased from Transduction Laboratories. Anti-Ack-1 polyclonal antibody sc-323 (Santa Cruz Laboratories) was raised against a C-terminal peptide fragment, NLEQAGCHLLGSWGPAHHKR (amino acids 1,072–1,091). Anti-Cdc42 monoclonal antibodies were
obtained from Santa Cruz Laboratories. Monoclonal antibody against MHC
class I molecules was obtained from Pharmingen.
Plasmids.
The full-length Ack-1 sequence was excised from the plasmid pBluescript SKAck-1 by digestion with EcoRI25. The purified fragment was then ligated into
pBKRSV (Stratagene) digested with EcoRI. The ligated plasmid was then used
to transform Escherichia coli strain DH5α. The purified plasmid was sequenced
at the Microchemical Facility of the University of Minnesota to verify antisense
orientation and was subsequently designated pBKRSV-Ack-1A.S. The pXJHAAck-1(K163A) kinase-inactive Ack-1 construct was a gift from E. Manser. Plasmids expressing glutathione-S-transferase (GST)-conjugated PBD were used
to estimate the levels of Cdc42 activation as described 45. Dominant-negative
Cdc42 (Cdc42(17N)) and constitutively active Cdc42 (Cdc42(12V)) in pZip
were gifts from C. Der. The pKHSH3cas construct was generated as described10.
pcDL-SRα-p130cas(ΔSD) was generated as described28. The p130cas(ΔSD) insert was liberated from the pcDL-SRα vector by SalI/EcoRI digestion and was
ligated into SalI/EcoRI-digested pBKRSV (Stratagene). The reporter plasmid
pHook-1 was purchased from Invitrogen.
Transfections and selection.
Cells were grown in six-well plates to about 60% confluency. Cells were then
transfected with 2μg of the vector of interest along with 1μg pHook selection
vector using the clonfectin transfection reagent (Clontech). Briefly, transfection
media containing 3μg clonfectin and plasmids were mixed in serum-free EMEM
for 30 min, after which the transfection media were applied to the cells. Transfection media were removed 3 h later and replaced with standard growth media.
36 h later, melanoma cells were collected with PBS/1mM EDTA and washed
several times in serum-free EMEM. Cells were then mixed with CaptureTec
selection beads (Invitrogen) for 30 min at 37°C; the transfected cells were removed through magnetic separation. Selected cells were washed twice in serumfree media and used immediately in experiments.
Preparation of recombinant CS1 (rIIIcs).
Recombinant CS1 (rIIIcs), representing the alternatively spliced type IIICS domain of human fibronectin, was prepared as described below. A plasmid encoding the C-terminal portion of cellular fibronectin, provided by M.-L. Chu, served
as a template for amplification by the polymerase chain reaction (PCR). Synthetic oligonucleotides complementary to fibronectin nucleotides 5,881–5,901
(5′) and 6,184–6,204 (3′) and containing 5′ BamHI/3′ EcoRI sites were used as
primers for PCR to generate the DNA encoding the type IIICS α4β1-integrinbinding sequence. Template DNA and 1μgml–1 primer were mixed with 1×PCR
reaction buffer containing 1.5 mM MgCl2 and denatured for 5 min at 95°C. PCR
was performed for 30 cycles of the following sequence: 60 s at 62°C, 90 s at
72°C, and 60 s at 95°C, followed by a final, 5-min extension at 72°C. The PCR
product was ligated into the pGEX-2T vector through the EcoRI and BamHI
sites and verified by sequencing. The resulting plasmid encoding the GST–IIICS
fusion protein was used to transform E. coli strain BL21(DE3) (Stratagene).
Overnight cultures were diluted 1:10 in fresh LB media containing 50 μg ml–
1 ampicillin and incubated for 1 h at 37°C. Protein synthesis was induced by the
addition of isopropyl-β-D-thiogalactoside (IPTG) to 1mM for 2.5 h at 37°C. Following centrifugation, the bacterial pellets were resuspended in 1:200 volume
cold extraction buffer (PBS, 1% Triton-X100, 0.1% SDS, 10mM EDTA, 1mM
phenylmethylsulphonyl fluoride (PMSF), 1mM NEM, plus 20μg ml–1 each of
antipain, aprotinin and leupeptin) and subjected to brief sonication on ice. The
insoluble cell debris were removed by centrifugation and the cleared supernatant added to a glutathione–Sepharose affinity column that was equilibrated with
phosphate buffered saline (PBS). The column was washed with 50 ml 50mM
Tris HCl, pH 7.4. The GST–IIICS fusion protein was then eluted with 5mM reduced glutathione in 50 mM Tris-HCl at pH 7.4. Finally, the eluted protein was
assayed for purity and molecular weight by SDS–PAGE.
Cell-spreading assays.
Cells were collected with PBS/1mM EDTA and washed twice with serum-free
EMEM. Cells were adjusted to a final concentration of 5×104 cells ml–1 in serum-free EMEM. 5×103 cells were added to each well of 96-well plates coated
with rIIIcs, monoclonal antibody 9.2.27, or both. The cells were incubated at
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37°C for 60 min and washed gently with serum-free EMEM. Cells were fixed
and stained using DiffQuik solutions (Baxter Inc., Miami, FL). Occupied cell
areas were quantified under a microscope at a magnification of ×40. Cell borders were traced electronically; the areas were calculated using a Semi Automatic Image Analysis System (Optomax Inc., Hollis, NH). Statistical significance was determined using Student’s t-test.
Cdc42 activity assay.
GST–PBD beads were prepared as described46,47. Cdc42 activity was assayed as
described46,47 with minor modifications. Briefly, A375SM cells were collected
in 3 mM EDTA/PBS and were washed twice in serum-free media and divided
into equal aliquots, each containing 5×105 cells. MCSP was clustered with antibody-coated magnetic beads as described above. RIPA buffer (500 mM NaCl,
1% NP-0, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0, 10mM MgCl2,
1mM PMSF, 1mM NEM, and 0.1mM pervanadate) was added to cell–bead conjugates; this step was followed by brief sonication and centrifugation. Lysates
were normalized for protein content and were added to 20 μg GST–PBD beads,
then incubated at 4°C with shaking for 30 min. Beads were washed 3–5 times in
HBS wash buffer (20 mM HEPES, pH 7.5, 120mM NaCl, 1% NP-40, 10 mM
MgCl2). Samples were reduced and electrophoresed in 15% SDS–PAGE, and visualized by western blotting using anti-Cdc42 monoclonal antibodies (see text).
In vitro kinase assays.
Cells (2×106) were lysed in immunoprecipitation buffer (50 mM Tris-HCl, pH
7.3, containing 1% Brij 58, 0.15 M NaCl, 2mM MgCl2, 1 mM PMSF, 1 mM
NEM and 0.1 mM pervanadate). Lysates were precleared and immunoprecipitated for 4 h at 4°C using the appropriate antibodies conjugated to protein-G–
agarose beads. The beads were washed four times with wash buffer (20 mM
Tris-HCl, pH 8.2, 150 mM NaCl, 2 mM MgCl2, 1 mM PMSF, 1 mM NEM, 0.1
mM pervanadate and 0.5% Brij 58). The beads were then washed in NH buffer
(40 mM HEPES, pH 7.2, 150 mM NaCl, 0.1 mM pervanadate). The beads were
resuspended in NH buffer and incubated for 10 min at room temperature with
labelling buffer containing 10 mM Tris, pH 7.4, 10 mM MgCl2, 0.1 mM pervanadate, 10 μCi [γ-32P]ATP (ICN). When examining phosphorylation of exogenous substrates, we added 10 μg MBP to the labelling buffer.
Radiolabelled proteins were separated by SDS–PAGE using a 7.5% running
gel and a 5% stacking gel under reducing conditions and visualized by autoradiography.
Co-immunoprecipitation, SDS–PAGE and western blotting.
Cells (2×106) were incubated with 9.2.27-, P4C2-, or anti-MHC I-coated magnetic beads (Dynal) at a ratio of 50 beads per cell for 3–5 min at 37°C. Cell–
bead aggregates were collected on a magnet and lysed for 20 min at 4°C in lysis buffer containing 50 mM Tris-HCl, pH 7.3, 1% Brij 58, 0.15 M NaCl, 1 mM
PMSF, 1 mM NEM and 1 mM pervanadate. The bead–protein complexes were
washed with lysis buffer and associated proteins released by brief sonication in
1% SDS. The solution was diluted in immunoprecipitation buffer containing 1%
Triton-X100, 0.15 M NaCl, 1 mM PMSF, 1 mM NEM and 1 mM pervanadate.
The proteins were then immunoprecipitated using various antibodies, separated
on 7.5% or 15% separating gels with 5% stacking gel, and transferred to Immobilon-P membrane. The membranes were blocked in PBS containing 1.5% BSA
at 4°C overnight. Membranes were incubated with the appropriate antibodies for
1 h at room temperature, washed with PBS containing 0.5% Tween20 and incubated with horseradish-peroxidase-conjugated secondary IgG (1:1,000) for 1 h
at room temperature. The membrane was extensively washed and proteins detected with the enhanced chemiluminescence (ECL) system (Amersham).
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